Leaflet NITROXOLINA-MIP 250mg soft capsules

Indicated for: bacterial infections

Route of administration: oral

Substance: nitroxoline (antibacterial antibiotic)

ATC: J01XX07 (Antiinfectives for systemic use | Other antibacterials)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Colitis / severe diarrhea
Colitis / severe diarrhea

Seek medical advice if severe or persistent diarrhea occurs.

Nitroxoline is an antibiotic used to treat urinary tract infections caused by sensitive bacteria. This medication works by inhibiting bacterial DNA synthesis, thereby preventing the multiplication of pathogenic microorganisms.

Nitroxoline is effective against a wide range of bacteria, including Escherichia coli, Proteus, and Klebsiella. It is primarily used for acute and chronic urinary tract infections, such as cystitis and pyelonephritis.

The drug is generally well-tolerated but may cause side effects such as nausea, vomiting, or allergic reactions. It is important to follow the prescribed dosage to avoid the development of bacterial resistance.

Nitroxoline is not recommended during pregnancy or breastfeeding unless the benefits outweigh the risks. Consult your doctor before use.

General data about NITROXOLINA-MIP 250mg

  • Substance: nitroxoline
  • Date of latest medicines list: 01-06-2026
  • Product code: W59990002
  • Concentration: 250mg
  • Pharmaceutical form: soft capsules
  • Quantity: 30
  • Product type: Generic medicine
  • Price: 126.42 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: CHEPHASAAR GMBH - GERMANIA
  • Holder: MIP PHARMA GMBH - GERMANIA
  • Number: 5701/2013/02
  • Shelf life: 2 years

Pharmaceutical forms available for nitroxoline